×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Did you mean:
BioLineRX
BioLineRx Reveals Cost-Saving Stem Cell Mobilization Data - TipRanks.com
Tipranks
Bioline RX Ltd Sponsored ADR (BLRX) has released an update. BioLineRx Ltd has announced the presentation of new economic model data for...
23 hours ago
BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates
PR Newswire
Reported significant commercial progress for APHEXDA® -- secured payer coverage representing ~95% of covered lives in the U.S.;...
1 month ago
BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ ...
ConchoValleyHomepage.com
Presentation Today, Monday, May 6, 2024 in Atlanta, Georgia -. TEL AVIV, Israel, May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX)...
1 day ago
BioLineRx doses first subject in Phase II pancreatic cancer trial
Clinical Trials Arena
BioLineRx has dosed the first subject in the Phase II trial evaluating motixafortide for the treatment of first-line pancreatic cancer.
2 months ago
BioLineRx's Pipeline Holds Promise
Yahoo Lifestyle Canada
BioLineRx Ltd.'s (BLRX) pipeline looks promising with candidates like BL-5010 (non-surgical removal of skin lesions); BL-1040 (preventing pathological...
3 days ago
Does BioLineRx (TLV:BLRX) Have A Healthy Balance Sheet?
Simply Wall Street
BioLineRx. BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases...
1 month ago
BioLineRx: Weighing Aphexda's Breakthrough Against Financial Challenges (NASDAQ:BLRX)
Seeking Alpha
BioLineRx's main product, Aphexda, was FDA-approved for stem cell mobilization in multiple myeloma patients. Read why BLRX stock is a...
5 months ago
BioLineRx Enhances Multiple Myeloma Treatment - TipRanks.com
Tipranks
Bioline RX Ltd Sponsored ADR (BLRX) has released an update. BioLineRx Ltd. has announced a poster presentation on their product, APHEXDA (motixafortide),...
3 weeks ago
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript
Yahoo Finance
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript March 26, 2024 BioLineRx Ltd. isn't one of the 30 most popular stocks among...
1 month ago
BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic ...
PR Newswire
BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for...
4 months ago